Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance

Valesca P. Retel; Manuela A. Joore; Wim H. van Harten

doi:10.1007/s10549-011-1769-7

Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance

Valesca P. Retel, Manuela A. Joore, Wim H. van Harten^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	627-636
Journal	Breast Cancer Research and Treatment
Volume	131
Issue number	2
DOIs	https://doi.org/10.1007/s10549-011-1769-7
Publication status	Published - Jan 2012

Keywords

Head-to-head comparison
70-gene signature
MammaPrint
21-gene recurrence score
Oncotype DX
Cost-effectiveness analysis

Access to Document

10.1007/s10549-011-1769-7

Cite this

@article{b32baa41e6bd4c66b2b10a1a085258aa,

title = "Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance",

keywords = "Head-to-head comparison, 70-gene signature, MammaPrint, 21-gene recurrence score, Oncotype DX, Cost-effectiveness analysis",

author = "Retel, {Valesca P.} and Joore, {Manuela A.} and {van Harten}, {Wim H.}",

year = "2012",

month = jan,

doi = "10.1007/s10549-011-1769-7",

language = "English",

volume = "131",

pages = "627--636",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer, Cham",

number = "2",

}

TY - JOUR

T1 - Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance

AU - Retel, Valesca P.

AU - Joore, Manuela A.

AU - van Harten, Wim H.

PY - 2012/1

Y1 - 2012/1

KW - Head-to-head comparison

KW - 70-gene signature

KW - MammaPrint

KW - 21-gene recurrence score

KW - Oncotype DX

KW - Cost-effectiveness analysis

U2 - 10.1007/s10549-011-1769-7

DO - 10.1007/s10549-011-1769-7

M3 - Article

C2 - 21947677

VL - 131

SP - 627

EP - 636

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -